Search Results 701-710 of 17881 for monoclonal antibody

1. Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery - Mayo Clinic

   Monoclonal antibodies, such as cetuximab and bevacizumab, may interfere with the ability of tumor cells to grow and spread. Giving irinotecan and cetuximab ...

2. Publications - Nikola A. Baumann, Ph.D. - Mayo Clinic

   Lack of observed interference by therapeutic monoclonal antibodies in select commonly utilized immunoassays. ... Antibody Detection Methods. J Clin ...

3. Combining Immunotherapy And Radiation Therapy To Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of ...

4. Future therapy for Graves' ophthalmology - Mayo Clinic

   ... antibodies predict a worse prognosis. ... Bahn says: "We treated GO fibroblasts with a high-affinity human stimulatory monoclonal antibody directed against TSH ...

5. A Study to Evaluate Firstline Pembrolizumab Alone or in Combination with Pemetrexed and Carboplatin in Induction/Maintenance or Postprogression in Treating Patients with Stage IV Non-squamous Non-small Cell Lung Cancer - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

6. Changes for visitors at Mayo Clinic in Rochester

   Monoclonal antibody treatment helps couple recover quickly from COVID-19. Related Articles. Mayo Clinic Minute: COVID-19 at-home tests and expiration dates ...

7. Research highlights in Neurology and Neurosurgery ― September 2019 - Mayo Clinic

   Staining with a monoclonal antibody was performed. All study participants had sufficient submandibular gland tissue on at least one side; 12 of the 14 ...

8. Expertise in defining and treating neuromyelitis optica spectrum disease - Mayo Clinic

   Three monoclonal antibody therapies — eculizumab, inebilizumab and satralizumab — have been approved for adults with NMOSD and AQP4-IgG autoantibodies.

9. Clinical trials - Oncology (Medical)

   Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

10. S1211, Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma - Mayo Clinic

    Monoclonal antibodies, such as elotuzumab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find ...